Cargando…

Polymeric ocular hydrogels and ophthalmic inserts for controlled release of timolol maleate

BACKGROUND: Ophthalmic drug delivery systems are the challenging subject for the researchers because of delicate nature of ocular membrane and preventive barriers leading to less than 1 % of Bioavailability. Reasons for reduced bioavailability are due to rapid pre corneal elimination, tear turnover,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Vinod, Bushetti, S. S., Raju, S. Appala, Ahmad, Rizwan, Singh, Mamta, Ajmal, Mohammad
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications Pvt Ltd 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103925/ https://www.ncbi.nlm.nih.gov/pubmed/21687359 http://dx.doi.org/10.4103/0975-7406.80773

Ejemplares similares

Stimuli-sensitive hydrogels: A novel ophthalmic drug delivery system
por: Singh, Vinod, et al.
Publicado: (2010)

Formulation and In-vitro Characterization of Sustained Release Matrix Type Ocular Timolol Maleate Mini-Tablet
por: Mortazavi, Seyed Alireza, et al.
Publicado: (2014)

The impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapies
por: Radcliffe, Nathan M
Publicado: (2014)

Formulation and evaluation of stimuli-sensitive hydrogels of timolol maleate and brimonidine tartrate for the treatment of glaucoma
por: Dubey, Akhilesh, et al.
Publicado: (2014)

Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma
por: Wu, Hai Wei, et al.
Publicado: (2017)

Optimization of Thermoreversible In Situ Nasal Gel of Timolol Maleate
por: Jagdale, Swati, et al.
Publicado: (2016)

From Eye Drops to ICU, a Case Report of Three Side Effects of Ophthalmic Timolol Maleate in the Same Patient
por: Rana, Muhammad Asim, et al.
Publicado: (2015)

Effects of 0.5% Timolol Maleate Ophthalmic Solution on Heart Rate and Selected Echocardiographic Indices in Apparently Healthy Cats
por: Gunther‐Harrington, C.T., et al.
Publicado: (2016)

Carbopol/Chitosan Based pH Triggered In Situ Gelling System for Ocular Delivery of Timolol Maleate
por: Gupta, Swati, et al.
Publicado: (2010)

Effect of dacryocystorhinostomy on systemic adverse effects of topical timolol maleate
por: Roy, Kakoli, et al.
Publicado: (2012)

Sick sinus syndrome associated with topical timolol maleate instillation
por: Walia, Harpreet S., et al.
Publicado: (2011)

Topical timolol maleate: An effectual and safe recourse for infantile hemangiomas
por: Bhat, Yasmeen Jabeen, et al.
Publicado: (2016)

Prolonged central nervous system and respiratory depression in preterm neonates after exposure to brimonidine tartrate and timolol maleate ophthalmic drops
por: Azarcon, Corrina P., et al.
Publicado: (2020)

Safety and Efficacy of Adding Fixed-Combination Brinzolamide/Timolol Maleate to Prostaglandin Therapy for Treatment of Ocular Hypertension or Glaucoma
por: Hommer, Anton, et al.
Publicado: (2015)

Magnesium Hydroxide Nanoparticles Improve the Ocular Hypotensive Effect of Twice Daily Topical Timolol Maleate in Healthy Dogs
por: Kita, Mizuki, et al.
Publicado: (2021)

Poly(Sulfobetaine Methacrylate-co-Vinyl Pyrrolidone) Hydrogels as Potential Contact Lenses Delivery Systems for Timolol Maleate
por: Nikolova, Denitsa, et al.
Publicado: (2023)

Comment on “Effect of dacryocystorhinostomy on systemic adverse effects of topical timolol maleate”
por: Arunachalam, Cynthia
Publicado: (2013)

Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
por: Inoue, Kenji, et al.
Publicado: (2015)

A Comfort Survey of Timolol Hemihydrate 0.5% Solution Once or Twice Daily vs Timolol Maleate in Sorbate
por: Stewart, William C, et al.
Publicado: (2013)

Randomized trial comparing three fixed combinations of prostaglandins/prostamide with timolol maleate
por: Kelly Rigollet, Jaime Pablo, et al.
Publicado: (2011)

Effects of timolol maleate eye drops on experimentally dilated cardiomyopathy and healthy rabbits
por: Isaka, Mitsuhiro, et al.
Publicado: (2021)

Quality of dorzolamide hydrochloride and timolol maleate containing eye drops distributed online
por: Merczel, Sára, et al.
Publicado: (2023)

Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension
por: Bell, Nicholas P, et al.
Publicado: (2010)

Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma
por: Wang, Yulong, et al.
Publicado: (2020)

Association between Ophthalmic Timolol and Hospitalisation for Bradycardia
por: Pratt, Nicole L., et al.
Publicado: (2015)

Development and evaluation of polycaprolactone-based electrospun nanofibers containing timolol maleate as a sustained-release device for treatment of glaucoma: in vivo evaluation in equine eye
por: Mirzaeei, Shahla, et al.
Publicado: (2022)

Effect of timolol maleate (0.5%) in the management of myopic regression post laser-assisted in-situ keratomileusis: Clinical and topographical outcomes
por: Singh, Aastha, et al.
Publicado: (2020)

A novel fixed-combination timolol-netarsudil-latanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension
por: Wang, Tao, et al.
Publicado: (2022)

Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue
por: Nakano, Tadashi, et al.
Publicado: (2016)

Conjunctival changes and inflammatory aspects in rabbits' conjunctivas induced by fixed combinations of prostaglandin analogues and timolol maleate
por: de Faria, Nubia Vanessa Lima, et al.
Publicado: (2013)

Improved bioavailability of timolol maleate via transdermal transfersomal gel: Statistical optimization, characterization, and pharmacokinetic assessment
por: Morsi, Nadia M., et al.
Publicado: (2016)

Bilateral Choroidal Detachment Induced by Unilateral Application of a Fixed Combination of Topical Timolol Maleate and Brinzolamide
por: DONMEZ, Oya, et al.
Publicado: (2016)

Ophthalmic Timolol and Hospitalization for Symptomatic Bradycardia and Syncope: A Case Series
por: Abbas, Syed A, et al.
Publicado: (2020)

Ocular surface evaluation in patients treated with a fixed combination of prostaglandin analogues with 0.5% timolol maleate topical monotherapy: a randomized clinical trial
por: Russ, Heloisa Helena, et al.
Publicado: (2013)

Evaluation of the efficacy and safety of topical timolol maleate combined with oral propranolol treatment for parotid mixed infantile hemangiomas
por: Tong, Shuang, et al.
Publicado: (2016)

Infantile Hemangiomas with Minimal and Arrested Growth: Clinical Features and Treatment Outcomes with 0.5% Topical Timolol Maleate
por: Bae, Kyung-Nam, et al.
Publicado: (2021)

Efficacy and safety of fixed-combination bimatoprost/timolol ophthalmic solution
por: Moon, Suk Bae, et al.
Publicado: (2017)

Bimatoprost 0.03%/timolol 0.5% preservative-free ophthalmic solution versus bimatoprost 0.03%/timolol 0.5% ophthalmic solution (Ganfort) for glaucoma or ocular hypertension: a 12-week randomised controlled trial
por: Goldberg, Ivan, et al.
Publicado: (2014)

Safety and efficacy of changing to the travoprost/timolol maleate fixed combination (DuoTrav) from prior mono- or adjunctive therapy
por: Pfeiffer, Norbert, et al.
Publicado: (2010)

Assessment of ocular hypotensive effect and safety 12 months after changing from an unfixed combination to a latanoprost 0.005% + timolol maleate 0.5% fixed combination
por: Inoue, Kenji, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bavffoi7m7ms94k063ejqf49k0